Q2 Bummer for Quest, Though Esoteric Testing 'Performing Well'

The company said 2010 revenue would be 1 percent below 2009's as opposed to previous projections, which said they would be 1 percent to 2 percent better. An analyst suggested cost cuts.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.